Efficacy of CPPLAI in Laparoscopic Sleeve Gastrectomy Patients

• Status: Recruiting
• Trial end date: 2021-07-07
• Target enrollment: 0
• Participant gender: All

Summary

The high demand for bariatric surgery due to the increasing prevalence of obesity worldwide necessitate evidence-based clinical pathway such as Enhanced Recovery After Bariatric Surgery (ERABS). The paradigm of surgery has been shifted from open to laparoscopic in morbidly obese patients. Laparoscopic Sleeve Gastrectomy (LSG) is the most common procedure performed in our institute for sustained weight loss and amelioration of obesity-related comorbidities. Pain control in ERABS is one of the key factors for improved outcomes. Surgery induced acute postoperative pain, stress response and fatigue lead to prolonged convalescence and hospital stay. Optimal titrated safe postoperative pain management in LSG patients still remains a challenge.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: King Khalid University Hospital
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• American Society of Anesthesiologist (ASA) physical status I-III

• Age 18-60 years

• Either gender

• Obese patients (BMI >35 for laparoscopic sleeve gastrectomy

Exclusion Criteria:

• American Society of Anesthesiologist (ASA) physical status IV

• Patients uncontrolled HTN

• Anticipated difficult intubation

• Allergic to morphine

• Clinically significant neurological, cardiovascular, renal hepatic disease planned for postoperative surgical intensive care (SICU) admission

• History of drug abuse or chronic opioid use